Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Combination of Solifenacin and Tadalafil Versus Solifenacin Alone in Treatment of Overactive Bladder in Females

NCT07312955 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07312955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Combination of Solifenacin and Tadalafil Versus Solifenacin Alone in Treatment of Overactive Bladder in Females
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2025
Completion date
November 15, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder